After a decade of stalled progress, a flurry of new studies is sparking hope in the fight against the deadly skin cancer melanoma. Results being presented at the annual meeting of the American Society of Clinical Oncology in Chicago are showing the promise of two experimental drugs and combination therapies. “The field for melanoma is changing so incredibly rapidly; it’s hard to even keep up with for us,” said Dr. F. Stephen Hodi of the Dana-Farber Cancer Institute.
Unlimited access to BostonGlobe.com for only 99 cents for the first 4 weeks.Sign up
Are you a home delivery subscriber?
Get FREE access as part of your print subscriptionStart Here
Contact us for help